Serum IgG Response to a Conserved Domain of Commensal Flagellins Predicts Future Risk of Crohn’s Disease in First-Degree Relatives
Richard Y. Wu(University of Toronto), Kenneth Croitoru(Mount Sinai Hospital), Charles O. Elson(University of Alabama at Birmingham), Levinus A. Dieleman(University of North Carolina at Chapel Hill), Sean Jeong(Mount Sinai Hospital), Brian Bressler(University of British Columbia), Lennard W. Duck(University of Alabama at Birmingham), A. Hillary Steinhart(Mount Sinai Hospital), Mingyue Xue(Mount Sinai Hospital), Dan Turner(Hebrew University of Jerusalem), Wei Xu(Princess Margaret Cancer Centre), Qing Zhao(University of Alabama at Birmingham), Sun-Ho Lee(Mount Sinai Hospital), Anne M. Griffiths(Hospital for Sick Children), Colette Deslandres(Centre Hospitalier Universitaire Sainte-Justine), David R. Mack(Children's Hospital of Eastern Ontario), Charles N. Bernstein(University of Manitoba), John K. Marshall(Population Health Research Institute), Williams Turpin(Mount Sinai Hospital), Remo Panaccione(University of Calgary), G Aumais(Hôpital Maisonneuve-Rosemont)
Cited by 3
Related Papers
A Genome-Wide Association Study Identifies <i>IL23R</i> as an Inflammatory Bowel Disease Gene
|Science|2006|3k
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
|New England Journal of Medicine|2013|2.7k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
Large-scale association analyses identify host factors influencing human gut microbiome composition
|Nature Genetics|2021|1.9k
Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
|New England Journal of Medicine|2016|1.8k